about
Pulmonary applications and toxicity of engineered nanoparticlesNanotechnology-based inhalation treatments for lung cancer: state of the artNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesMetabolic Functions of the Lung, Disorders and Associated PathologiesCharacterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airwaysCationic nanoparticles directly bind angiotensin-converting enzyme 2 and induce acute lung injury in miceInnate Immune Responses to Nanoparticle Exposure in the LungIn vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug deliveryEvaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial modelThe interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticlesChemical Species, Micromorphology, and XRD Fingerprint Analysis of Tibetan Medicine Zuotai Containing MercuryStability and efficacy of synthetic cationic antimicrobial peptides nebulized using high frequency acoustic waves.Polymeric Nanostructures for Imaging and TherapyPulmonary monoclonal antibody delivery via a portable microfluidic nebulization platformManganese-loaded lipid-micellar theranostics for simultaneous drug and gene delivery to lungsPolymeric nanoparticles for pulmonary protein and DNA delivery.Nanomedicine in pulmonary deliveryPolymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblendsImpact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeuticsTemozolomide-based dry powder formulations for lung tumor-related inhalation treatment.Advances in device and formulation technologies for pulmonary drug delivery.Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.Nanotechnology approaches for inhalation treatment of fibrosis.New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosisHigh-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.Production, characterisation, and in vitro nebulisation performance of budesonide-loaded PLA nanoparticles.Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken designInitial observations of cell-mediated drug delivery to the deep lungAggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery.Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanopartiSelf-Assembled Nanospheres for Encapsulation and Aerosolization of Rifampicin.Exploring targeted pulmonary delivery for treatment of lung cancer.Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.Combined computational and experimental studies of molecular interactions of albuterol sulfate with bovine serum albumin for pulmonary drug nanoparticles.A new method for measuring lung deposition efficiency of airborne nanoparticles in a single breath.Nanomedicine for the management of lung and blood diseases.Update on antibiotics for infection control in cystic fibrosis.Nanotechnology-Based Approach in Tuberculosis Treatment.Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention.
P2860
Q24650775-EE81E9F0-7DC5-4C7D-BC6E-E1A18819A87BQ26774177-B2543393-B21B-492E-A316-B4D6F960D024Q26786162-694CD197-D181-45FC-BBAE-75E94FA63413Q28072037-F8012D33-7988-4CDB-8DD8-A312E101379CQ28386376-E712A263-253A-4644-969C-E44FC37E4899Q28391763-24E005E5-2BA2-4DA4-8944-A442CC783F9AQ28394494-B7DE75C5-BE4D-4072-8F1B-18A8A40F8901Q28396006-47951511-E420-4C39-97FE-4964FB30BCA0Q28397573-850DA0A0-8CF5-4595-809D-B62F7BFC9644Q28481207-3069657C-465D-4CC8-B4B4-087230796131Q28822527-8ECEDBD3-3439-4D1C-AE2F-7C91810E6FACQ30354710-68A90E43-3E09-495F-8654-D53F768912D1Q30372383-5A7EB818-00C8-44BE-A8CD-D95997E7DE0FQ30386192-4739361A-6E63-488E-9D7D-DBEDA079696BQ30587526-AC523F27-9DB0-45CB-B923-8D64B6084A4DQ33560960-D263A27C-15AD-4F07-A7FB-F0AAD5D9C759Q33572981-DE11357D-94A8-4AB5-88F1-A13F09184FDFQ33574188-0010AE19-EEB9-499D-A7DE-C552DCD8C0C0Q33583948-1613B473-B01E-4EDC-AF93-7C2E8476C824Q33758340-B9B0F9BD-2B59-4B65-AEEF-644D7545DDC1Q33962567-D54D14F2-8B7B-4C66-A259-4089B790713DQ34293599-1A571AE6-867D-4580-8BEE-5C4949C7918CQ34449624-CBF7D47F-C9EF-4C5E-9A5E-3DF75AF1C48CQ34456015-67C58D87-4043-46DC-8910-D71AB7F9A4F5Q34577430-B1C13E51-6BD0-4C99-A02A-78C58B2B4173Q34871862-7A43199F-CD25-4E9D-96C3-7AB2C562572AQ35138923-47854735-70BA-4D28-85E8-15E28033F51AQ35796474-B61C77B1-008E-4CB1-A447-9177AAD737C4Q35884617-163FD925-A3A2-4224-A2EE-D09DA11B0452Q36001570-06E602C6-35BF-49FE-9F71-89C70A55FE4CQ36555371-70284137-C05F-40AC-9E84-F98A927B0B8EQ36688341-10C0C3D0-FD75-41F1-ABCC-A95A1C3038A4Q36942012-9EB357FF-EEE6-4D93-B58F-BB79E3C72CA8Q37103466-5C30AD7F-FEB4-4324-8071-40D7F764D268Q37269769-50A2118D-B945-47C5-B620-4C4F8F4AA7DEQ37397186-B27EEE50-8B8F-41CF-9AF8-B2F97C3BD6DCQ37426681-F314C245-8C31-4F12-8252-9EFB0C35547FQ37608274-95E4F69A-FAFB-4F5A-A352-90F10230BAADQ37624974-37C128BA-61EB-40C7-8D9F-C51008C0B9F2Q37672440-0A558C7B-204E-4A12-9FC7-9F8B1D374BBB
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nanoparticles for drug delivery to the lungs.
@en
type
label
Nanoparticles for drug delivery to the lungs.
@en
prefLabel
Nanoparticles for drug delivery to the lungs.
@en
P2093
P1476
Nanoparticles for drug delivery to the lungs.
@en
P2093
Brian L Pulliam
David A Edwards
Jean C Sung
P304
P356
10.1016/J.TIBTECH.2007.09.005
P577
2007-11-08T00:00:00Z